Clinical Trial for South Africa

James Cape, Chairman, Retina South Africa signs the documents that start the negotiations to bring the first ever clinical trial to treat an Inherited Retinal Disorder to South Africa. Details of the trial are strictly confidential but all patients with a clinical diagnosis of Leber Congenital Amaurosis [LCA] or early onset Retinitis Pigmentosa [RP] are urged to contact Retina South Africa urgently. A genetic diagnosis is a pre-requisite for possible inclusion in the trial. Hopefully this is the first of many trials but sadly, many people who stand to benefit from such trials do not have a genetic result.

James Cape

Sign Up For Our E-Newsletter

To receive our E-Newsletter right to your inbox, please complete this form

Please leave this field empty.